Retraction
This article [1] has been retracted by the editors of BMC Research Notes because, contrary to the statement in the manuscript, Moi University Institutional Research and Ethics Committee (IREC) has confirmed that ethics approval was not obtained to conduct this study. In addition, the authors did not have permission to use data from the DREAM program.
Footnotes
The online version of the original article can be found at 10.1186/1756-0500-7-52
Contributor Information
Erastus K Ngemu, Email: ngemuerastus@gmail.com.
Christopher Khayeka–Wandabwa, Email: khayekachris@yahoo.com.
Eliningaya J Kweka, Email: Pat.kweka@gmail.com.
Joseph K Choge, Email: chogekjoseph@gmail.com.
Edward Anino, Email: eanino6@yahoo.com.
Elijah Oyoo-Okoth, Email: elijaoyoo2009@gmail.com.
References
- 1.Ngemu EK, Khayeka–Wandabwa C, Kweka EJ, Choge JK, Anino E, Oyoo-Okoth E. Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women. BMC Res Notes. 2014;7:52. doi: 10.1186/1756-0500-7-52. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]